We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+474.07%
AUM
$9.88B
AUM Growth
+$1.08B
Cap. Flow
+$551M
Cap. Flow %
5.58%
Top 10 Hldgs %
18.26%
Holding
362
New
31
Increased
114
Reduced
84
Closed
30

Sector Composition

Rank Sector Weight
1 Industrials 28.87%
2 Technology 17.88%
3 Consumer Discretionary 14.78%
4 Healthcare 14.24%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
51
DexCom
DXCM
$32.8B
$68.8M 0.7%
4,796,212
+1,303,200
+37% +$16.9M
ATHN
52
DELISTED
Athenahealth, Inc.
ATHN
$68.1M 0.69%
511,863
+118,411
+30% +$15.1M
NCMI icon
53
National CineMedia
NCMI
$391M
$65.8M 0.67%
959,016
+43,860
+5% +$2.91M
HBI
54
DELISTED
Hanesbrands
HBI
$65.5M 0.66%
+3,130,952
New +$66.9M
CASY icon
55
Casey's General Stores
CASY
$31.8B
$63.5M 0.64%
567,453
+54,934
+11% +$6.28M
MIDD icon
56
Middleby
MIDD
$6.09B
$62.9M 0.64%
465,968
+53,056
+13% +$6.49M
JBTM
57
JBT Marel
JBTM
$7.4B
$62.2M 0.63%
561,707
-80,171
-12% -$8.76M
RVNC
58
DELISTED
Revance Therapeutics, Inc.
RVNC
$62.1M 0.63%
1,736,734
-398,787
-19% -$11.5M
NBIX icon
59
Neurocrine Biosciences
NBIX
$16.9B
$61.9M 0.63%
797,714
-90,232
-10% -$6.15M
EXAS
60
DELISTED
Exact Sciences
EXAS
$58.3M 0.59%
1,109,674
-848,916
-43% -$45.3M
HELE icon
61
Helen of Troy
HELE
$682M
$58M 0.59%
601,577
+192,386
+47% +$17.7M
CYBR
62
DELISTED
CyberArk
CYBR
$57.5M 0.58%
1,389,765
+213,302
+18% +$9.34M
ATRA icon
63
Atara Biotherapeutics
ATRA
$75.4M
$57M 0.58%
125,873
+14,844
+13% +$5.48M
CDNS icon
64
Cadence Design Systems
CDNS
$93.1B
$56.8M 0.57%
1,357,119
-1,380,912
-50% -$59.4M
JUNO
65
DELISTED
Juno Therapeutics, Inc.
JUNO
$55.4M 0.56%
1,212,051
-101,881
-8% -$5.08M
MMS icon
66
Maximus
MMS
$3.27B
$53.1M 0.54%
741,734
+48,128
+7% +$3.24M
ELGX
67
DELISTED
Endologix Inc
ELGX
$52.9M 0.54%
989,011
+104,399
+12% +$5.51M
NVRO
68
DELISTED
NEVRO CORP.
NVRO
$52.7M 0.53%
762,929
-983
-0.1% -$78.6K
COO icon
69
Cooper Companies
COO
$14.4B
$51.9M 0.53%
953,544
+10,472
+1% +$612K
ABM icon
70
ABM Industries
ABM
$2.87B
$50.7M 0.51%
+1,344,068
New +$55.6M
MDSO
71
DELISTED
Medidata Solutions, Inc.
MDSO
$50.3M 0.51%
792,989
+121,808
+18% +$8.68M
DDD icon
72
3D Systems Corp
DDD
$456M
$50.2M 0.51%
5,807,983
+2,697,683
+87% +$27.7M
HCCI
73
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$49.8M 0.5%
2,290,730
+286,196
+14% +$5.77M
DBVT
74
DBV Technologies
DBVT
$791M
$49.4M 0.5%
200,768
+97,749
+95% +$28.3M
NEWR
75
DELISTED
New Relic, Inc.
NEWR
$49.1M 0.5%
849,956
+35,388
+4% +$1.93M

Similar funds

ArrowMark Colorado Holdings's Q4 2017 Portfolio in Review

As of Q4 2017, ArrowMark Colorado Holdings held 362 positions worth $9.88B, up 12% from $8.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

ArrowMark Colorado Holdings deployed $551M of net new capital in Q4 2017, opening 31 new positions and adding to 114 existing holdings. Its largest new stake was Switch, Inc. Class A Common Stock: 3,802,358 shares worth $69.2M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cadence Design Systems, an estimated $59.4M trimmed.

  • ArrowMark Colorado Holdings's largest Q4 2017 buy was Switch, Inc. Class A Common Stock: 3,802,358 shares worth $69.2M.
  • ArrowMark Colorado Holdings added most to Graphic Packaging in Q4 2017, an estimated $76.2M increase.
  • ArrowMark Colorado Holdings's biggest Q4 2017 reduction was Cadence Design Systems, cutting an estimated $59.4M.
  • ArrowMark Colorado Holdings fully exited Evolent Health in Q4 2017, selling an estimated $51.3M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 18% of its $9.88B portfolio in Q4 2017.
  • ArrowMark Colorado Holdings opened 31 new positions and closed 30 in Q4 2017.
  • ArrowMark Colorado Holdings's portfolio value rose 12% quarter-over-quarter to $9.88B.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.